Boeing Co vs Novavax Inc — how do they compare? Boeing Co trades at $233.4 (market cap $184.35B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Boeing Co is far larger — about 140.7× Novavax Inc's market cap, and Boeing Co pays a 0.03% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| BA | NVAX | |
|---|---|---|
Market Cap | $184.35B | $1.31B |
Volume | 7,591,579 | — |
Sector | Industrials | Health |
52-Week High | $252.15 | $11.19 |
52-Week Low | $179.12 | $6.22 |
Enterprise Value | $210.23B | $889.30M |
Dividend Yield | 0.03% | — |
Trailing returns across standard periods
Latest headlines on both assets
The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.
Read more on BA →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →